Targeting Notch signaling in pancreatic cancer patients--rationale for new therapy

P Mysliwiec1, M J Boucher

  • 1Service de Gastroentérologie (Labo), Département de Médecine, Faculté de Médecine et des Sciences de la Santé (CHUS -Fleurimont), Université de Sherbrooke, Sherbrooke, Canada.

Advances in Medical Sciences
|September 18, 2009
PubMed

Insights

Pancreatic cancer remains deadly, with little survival improvement. This review explores the Notch pathway

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Pancreatic cancer has dismal survival rates despite advances in molecular understanding.
  • Effective prevention, early diagnosis, and treatment strategies require deeper insight into disease mechanisms.

Purpose of the Study:

  • To review the role of the Notch signaling pathway in pancreatic cancer.
  • To provide a rationale for targeting the Notch pathway in pancreatic cancer therapy.

Main Methods:

  • Literature review of studies investigating the Notch pathway in pancreatic cancer.
  • Analysis of molecular and cellular mechanisms linking Notch signaling to pancreatic cancer pathogenesis.

Main Results:

  • The Notch pathway is implicated in the initiation and progression of pancreatic cancer.
  • Evidence suggests Notch signaling is crucial for maintaining pancreatic tumors.

Conclusions:

  • The Notch pathway is a promising therapeutic target for pancreatic cancer.
  • Inhibiting the Notch pathway may offer new treatment strategies for patients.

Related Concept Videos

Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...